Alberto Clò
Alberto Clò
PhD presso Lab. Retrovirus, DIMES, Scuola di Medicina, Università di Bologna
Verified email at unibo.it
TitleCited byYear
Recent progress in the genetics of diabetic microvascular complications
YC Chang, EYC Chang, LM Chuang
World journal of diabetes 6 (5), 715, 2015
47*2015
Prospective evaluation of bone markers, parathormone and 1, 25-(OH) 2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir …
E Focà, D Motta, M Borderi, D Gotti, L Albini, A Calabresi, I Izzo, ...
BMC infectious diseases 12 (1), 38, 2012
372012
HIV-related mechanisms in atherosclerosis and cardiovascular diseases
D Gibellini, M Borderi, A Clo, S Morini, A Miserocchi, I Bon, C Ponti, ...
Journal of cardiovascular medicine 14 (11), 780-790, 2013
362013
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation
D Gibellini, E De Crignis, C Ponti, M Borderi, A Clò, A Miserocchi, P Viale, ...
Biochemical and biophysical research communications 401 (3), 429-434, 2010
342010
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line.
D Gibellini, M Borderi, E De Crignis, A Clo, A Miserocchi, P Viale, MC Re
The new microbiologica 33 (2), 109, 2010
342010
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures
I Bon, D Lembo, M Rusnati, A Clo, S Morini, A Miserocchi, A Bugatti, ...
PLoS One 8 (10), e76482, 2013
292013
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages
D Gibellini, A Clò, S Morini, A Miserocchi, C Ponti, MC Re
World journal of virology 2 (2), 91, 2013
292013
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells
D Gibellini, F Alviano, A Miserocchi, PL Tazzari, F Ricci, A Clò, S Morini, ...
Retrovirology 8 (1), 40, 2011
292011
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
MA Laginestra, PP Piccaluga, F Fuligni, M Rossi, C Agostinelli, S Righi, ...
Blood cancer journal 4 (11), e259, 2014
222014
Analysis of the effects of HIV‐1 Tat on the survival and differentiation of vessel wall‐derived mesenchymal stem cells
D Gibellini, A Miserocchi, PL Tazzari, F Ricci, A Clò, S Morini, C Ponti, ...
Journal of cellular biochemistry 113 (4), 1132-1141, 2012
162012
Antiretroviral molecules and cardiovascular diseases
D Gibellini, M Borderi, A Clò, S Morini, A Miserocchi, I Bon, MC Re
New Microbiol 35 (4), 359-75, 2012
152012
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients
A Clò, D Gibellini, D Damiano, F Vescini, C Ponti, S Morini, A Miserocchi, ...
New Microbiol 38 (3), 345-56, 2015
132015
IFI16 expression is related to selected transcription factors during B-cell differentiation
PP Piccaluga, C Agostinelli, F Fuligni, S Righi, C Tripodo, MC Re, A Clò, ...
Journal of immunology research 2015, 2015
92015
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection
I Bon, A Clo, M Borderi, V Colangeli, L Calza, S Morini, A Miserocchi, ...
International Journal of Infectious Diseases 17 (10), e875-e882, 2013
72013
Recent and long-lasting infections: The need of avidity testing in HIV-1 infected subjects.
MC Re, I Bon, N Grandi, A Miserocchi, S Morini, A Clo, G Furlini, ...
Microbiologica-Quarterly Journal of Microbiological Sciences 35 (4), 407, 2012
72012
HIV‐1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy
I Bon, O Turriziani, G Musumeci, A Clò, C Montagna, S Morini, L Calza, ...
Journal of medical virology 87 (2), 315-322, 2015
62015
Molecular bases of osteoporosis in HIV: the role of the virus and antiretroviral therapy
D Gibellini, M Borderi, E Vanino, A Clò, S Morini, L Calza, MC Re, P Viale
Clinical Reviews in Bone and Mineral Metabolism 10 (4), 236-245, 2012
22012
Studio della patogenesi di HIV-1 nel compartimento osseo: effetti della terapia antiretrovirale convenzionale e nuovi approcci all'eradicazione
A Clò
alma, 2014
2014
BONE TURN-OVER MARKERS IN HIV POSITIVE PATIENTS AFTER HAART: TENOFOVIR (TDF) plus EMTRICITABINE (FTC) plus ATAZANAVIR/RITONAVIR (ATV/R)-VS.-TDF plus FTC plus EFAVIRENZ (EFV …
E Foca, D Motta, M Borderi, I Izzo, A Calabresi, R Bellagamba, R Fezza, ...
INFECTION 39, S42-S42, 2011
2011
HIV-1 Tat protein enhances the RANKL/M-CSF-mediated osteoclast differentiation
M Borderi, D Gibellini, E de Crignis, A Miserocchi, A Clo, G Legnani, ...
INFECTION 38, 92-92, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–20